Why the study?
To revise the 2009 ACVIM guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs given substantial changes in management before heart failure onset and new diagnostic and treatment strategies.
Provides updated consensus recommendations for the diagnosis and treatment of myxomatous mitral valve disease in dogs.
No takes yet. Share an insight, caveat, or question.
Guideline updates should now direct revised pre-clinical MMVD management and advanced HF strategies in dogs; extends prior consensus recommendations.
Keene et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: